Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of COVID-19 virus by formulations containing curcumin, harmine, and isovanillin

Inhibition of COVID-19 virus by formulations containing curcumin, harmine, and isovanillin

US Patent 12053440 · Granted Aug 6, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Low-temperature synthesis of thymoquinone and harmaline compounds2025
Therapeutic agents and uses thereof2024
Methods for treating plasma cell neoplasm with human therapeutic agents2024
Inhibition of DYRK1A kinase2023
Inhibition of DYRK1A kinase2023
Inhibition of COVID-19 virus2023
Inhibition of COVID-19 virus2023
Inhibition of COVID-19 virus2023
Inhibition of COVID-19 virus2023
Harmine synthesis2023
Topical medicaments2022
Topical medicaments2022